These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 9027364)
21. Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor. Rajamahanty S; Alonzo C; Aynehchi S; Choudhury M; Konno S J Biomed Sci; 2010 Jan; 17(1):5. PubMed ID: 20102617 [TBL] [Abstract][Full Text] [Related]
22. Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays. Kim HJ; Park YI; Dong MS Toxicol In Vitro; 2006 Oct; 20(7):1159-67. PubMed ID: 16621434 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of androgen action by dehydroepiandrosterone sulfotransferase transfected in PC-3 prostate cancer cells. Chan J; Song CS; Matusik RJ; Chatterjee B; Roy AK Chem Biol Interact; 1998 Feb; 109(1-3):267-78. PubMed ID: 9566751 [TBL] [Abstract][Full Text] [Related]
24. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis. Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908 [TBL] [Abstract][Full Text] [Related]
25. Androgen regulation of parathyroid hormone-related peptide production in human prostate cancer cells. Pizzi H; Gladu J; Carpio L; Miao D; Goltzman D; Rabbani SA Endocrinology; 2003 Mar; 144(3):858-67. PubMed ID: 12586762 [TBL] [Abstract][Full Text] [Related]
26. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Yeap BB; Krueger RG; Leedman PJ Endocrinology; 1999 Jul; 140(7):3282-91. PubMed ID: 10385425 [TBL] [Abstract][Full Text] [Related]
27. Androgen-induced growth inhibition of androgen receptor expressing androgen-independent prostate cancer cells is mediated by increased levels of neutral endopeptidase. Shen R; Sumitomo M; Dai J; Harris A; Kaminetzky D; Gao M; Burnstein KL; Nanus DM Endocrinology; 2000 May; 141(5):1699-704. PubMed ID: 10803579 [TBL] [Abstract][Full Text] [Related]
28. Modulation of androgen receptor transcriptional activity by the estrogen receptor. Kumar MV; Leo ME; Tindall DJ J Androl; 1994; 15(6):534-42. PubMed ID: 7721655 [TBL] [Abstract][Full Text] [Related]
29. Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor gene. Hofbauer LC; Hicok KC; Schroeder MJ; Harris SA; Robinson JA; Khosla S J Cell Biochem; 1997 Sep; 66(4):542-51. PubMed ID: 9282332 [TBL] [Abstract][Full Text] [Related]
30. The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor. Mizokami A; Koh E; Fujita H; Maeda Y; Egawa M; Koshida K; Honma S; Keller ET; Namiki M Cancer Res; 2004 Jan; 64(2):765-71. PubMed ID: 14744796 [TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line. Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159 [TBL] [Abstract][Full Text] [Related]
32. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. van der Poel HG Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107 [TBL] [Abstract][Full Text] [Related]
33. Breast cancer: from estrogen to androgen receptor. Andò S; De Amicis F; Rago V; Carpino A; Maggiolini M; Panno ML; Lanzino M Mol Cell Endocrinol; 2002 Jul; 193(1-2):121-8. PubMed ID: 12161011 [TBL] [Abstract][Full Text] [Related]
34. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911 [TBL] [Abstract][Full Text] [Related]
35. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. Dai JL; Burnstein KL Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268 [TBL] [Abstract][Full Text] [Related]
36. Evidence for a novel mechanism of androgen resistance in the human prostate cancer cell line, PC-3. Tilley WD; Bentel JM; Aspinall JO; Hall RE; Horsfall DJ Steroids; 1995 Jan; 60(1):180-6. PubMed ID: 7792809 [TBL] [Abstract][Full Text] [Related]
38. CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells. He J; Lan X; Duan HL; Luo H; Zhou XD Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4477-4487. PubMed ID: 30058677 [TBL] [Abstract][Full Text] [Related]
39. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors. Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471 [TBL] [Abstract][Full Text] [Related]
40. Effects of Aroclors and individual PCB congeners on activation of the human androgen receptor in vitro. Schrader TJ; Cooke GM Reprod Toxicol; 2003; 17(1):15-23. PubMed ID: 12507654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]